Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2

M. Fernanda Amary, Stephen Damato, Dina Halai, Malihe Eskandarpour, Fitim Berisha, Fiona Bonar, Stan McCarthy, Valeria R. Fantin, Kimberly S. Straley, Samira Lobo, Will Aston, Claire L. Green, Rosemary E. Gale, Roberto Tirabosco, Andrew Futreal, Peter Campbell, Nadège Presneau, Adrienne M. Flanagan*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

258 Citations (Scopus)

Abstract

Ollier disease and Maffucci syndrome are characterized by multiple central cartilaginous tumors that are accompanied by soft tissue hemangiomas in Maffucci syndrome. We show that in 37 of 40 individuals with these syndromes, at least one tumor has a mutation in isocitrate dehydrogenase 1 (IDH1) or in IDH2, 65% of which result in a R132C substitution in the protein. In 18 of 19 individuals with more than one tumor analyzed, all tumors from a given individual shared the same IDH1 mutation affecting Arg132. In 2 of 12 subjects, a low level of mutated DNA was identified in non-neoplastic tissue. The levels of the metabolite 2HG were measured in a series of central cartilaginous and vascular tumors, including samples from syndromic and nonsyndromic subjects, and these levels correlated strongly with the presence of IDH1 mutations. The findings are compatible with a model in which IDH1 or IDH2 mutations represent early post-zygotic occurrences in individuals with these syndromes.

Original languageEnglish
Pages (from-to)1262-1265
Number of pages4
JournalNature Genetics
Volume43
Issue number12
DOIs
Publication statusPublished - Dec 2011
Externally publishedYes

Fingerprint

Dive into the research topics of 'Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2'. Together they form a unique fingerprint.

Cite this